(ZEROHEDGE) – EpiPens are auto-injectors containing epinephrine, a drug that can treat or reverse severe allergic reactions, potentially preventing death. The global epinephrine market was valued at $1.75 billion in 2022 and is projected to reach $4.08 billion by 2030. North America represents over 60% of the market. EpiPens, however, can be prohibitively expensive in…
The post Visualizing the massively varied cost of an EpiPen across major markets appeared first on WND.
This article was originally published by the WND News Center.
Go to the full page to view and submit the form.
This post originally appeared on WND News Center.